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1726-4Endothelial cell dysfunction and preeclampsiaPreeclampsia is a pregnancy-specific syndrome of hyper-
tension and proteinuria and one of the leading causes of per-
inatal morbidity and mortality.1 The pathogenesis of
preeclampsia, although not entirely clear, is typically abnor-
mal placental implantation, followed by endothelial dysfunc-
tion with subsequently resulting vasospasm, coagulopathy, or
changes in capillary permeability; this underscores the
importance of successfully established circulation networks
between the fetus and mother.1 These established circulation
networks require an ongoing sequential process, and one of the
most noteworthy facilitators of this process is the success of
angiogenesis. However, angiogenesis is a very complicated
procedure because normal physiological function is needed,
and many diverse pathologies and disease status indicators
also involve an active angiogenesis process.2 Endothelial
progenitor cells (EPCs) were characterized and isolated from
peripheral blood by Asahara et al3 in 1997, and are recruited to
vascular lesion sites. EPCs may play a critical role in the
repair of blood vessel damage, restoration of endothelial
function, or neoangiogenesis after the fetal period.4 Dysfunc-
tion of endothelial cells is a hallmark of many cardiovascular
diseases,5 and there is evidence that reductions in the number
and functionality of circulating EPCs might contribute to adult
cardiovascular disease.3 However, the role of circulating EPCs
on the development of preeclampsia is not conclusive.
The study by Parsanezhad et al6 in this issue of the Journal
of the Chinese Medical Association seems to be the first report
to study the differences between three distinct subsets of EPCs
of maternal peripheral blood, including circulating angiogenic
cells (CAC), colony-forming unit endothelial cells (CFU-
ECs), and endothelial colony-forming cells (ECFCs) in
women with and without preeclampsia. They show higher
numbers of CACs and ECFCs subsets in the peripheral blood
but fewer colony formation capacities in the peripheral blood
of pregnant women with preeclampsia compared with that of
women with normal pregnancy, suggesting that the function-
ality of CACs and ECFCs in women with preeclampsia was
decreased. By contrast, the number of CACs increases without
alternations in colony formation ability was found in women
with normal pregnancy.6
It is unclear why the high numbers of ECFCs in the
peripheral blood of women with preeclampsia did not con-
tribute to an elevated number of colony formations, suggesting
that ECFCs of women with and without preeclampsia mightx.doi.org/10.1016/j.jcma.2015.02.001
901/Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Assbe different in the phenotype. Unfortunately, the authors failed
to provide any additional evidence to support their findings. In
addition to the measurement of ECFC levels in the peripheral
blood of pregnant women with and without preeclampsia, the
following strategies might be required to characterize ECFC
phenotype, including investigation of cloning-forming ability,
proliferation, and migration toward vascular endothelial
growth factor-A and fibroblast growth factor-2, in vitro for-
mation of capillary-like structures, and in vivo vasculogenic
ability in immunodeficient mice. Without the aforementioned
experiments, the authors' claim that ECFCs in preeclampsia
have lost their functional capabilities is overestimated.6
Therefore, it is reasonable to suspend the aforementioned
conclusion. ECFCs are a subset of circulating endothelial
progenitor cells that participate in the formation of vasculature
during development.7 It is hard to believe that the absolute
number of ECFCs in the peripheral blood of pregnant women
with preeclampsia is increased compared with that of women
without preeclampsia. A recent study from Mu~noz-Hernandez
and colleagues7 did not find any statistically significant dif-
ference of phenotypic and functional characteristics of cord
blood ECFCs between pregnant women with and without
preeclampsia. By contrast, the ECFC level in preeclampsia
was statistically lower than in the control, with a median
abundance of 1 colony per 10 mL of cord blood and a 25th to
75th interquartile range of 0 to 4 colonies per 10 mL of cord
blood.7 In addition, a significant portion of the women with
preeclampsia in their study had no measurable ECFCs.7 This
finding was consistent after adjustment of most obstetric fac-
tors, suggesting that level of ECFCs was an independent factor
in preeclampsia.7
Moreover, recent studies have shown many important con-
founding factors on circulating levels of ECFCs, including body
mass index and gestational age.8 Furthermore, Yoder and col-
leagues9 demonstrated that early endothelial progenitor cells
that generate endothelial cell colony-forming units are hema-
topoietic in origin, fail to form perfused vessels in vivo, and are
clonally distinct from ECFCs; thus, in addition to variations in
the number of AC133þ/KDRþ/CD34þ endothelial progenitor
cells, which are distinguished from ECFCs, it remains unclear
whether preeclampsia altered baseline levels in the peripheral
blood ECFCs. The more unambiguously identified ECFCs,
based on well-known endothelial markers and functional
properties, may be needed to confirm the levels or roles ofociation. All rights reserved.
322 Editorial / Journal of the Chinese Medical Association 78 (2015) 321e322circulating ECFCs in the peripheral blood of pregnant women
with preeclampsia, because many biomarkers have been used in
an attempt to provide a much more effective tool in predicting
the risk of occurrence of preeclampsia.10
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